Professor Andrew Roberts is a world-leader in translational research into blood cancers. His laboratory work has discovered the function of key proteins in blood cells, and guided the development of new drugs to target BCL2. His clinical trial research has led to advances in therapy for patients undergoing donor stem cell transplants, and pioneered targeted therapies for incurable blood cancers. He champions health and medical science through service to NHMRC, as chair of the Cancer Council Victoria, as a director of a national clinical trials co-operative group and as a member of the Pharmaceutical Benefits Advisory Committee.